148 related articles for article (PubMed ID: 32676318)
1. Maximum standardized uptake value of primary tumor (SUVmax_PT) and horizontal range between two most distant PET-positive lymph nodes predict patient outcome in inoperable stage III NSCLC patients after chemoradiotherapy.
Roengvoraphoj O; Käsmann L; Eze C; Taugner J; Gjika A; Tufman A; Hadi I; Li M; Mille E; Gennen K; Belka C; Manapov F
Transl Lung Cancer Res; 2020 Jun; 9(3):541-548. PubMed ID: 32676318
[TBL] [Abstract][Full Text] [Related]
2. Analysis of primary tumor metabolic volume during chemoradiotherapy in locally advanced non-small cell lung cancer.
Roengvoraphoj O; Wijaya C; Eze C; Li M; Dantes M; Taugner J; Tufman A; Huber RM; Belka C; Manapov F
Strahlenther Onkol; 2018 Feb; 194(2):107-115. PubMed ID: 29116336
[TBL] [Abstract][Full Text] [Related]
3. Effect of PET/CT standardized uptake values on complete response to treatment before definitive chemoradiotherapy in stage III non-small cell lung cancer.
Ercelep O; Alan O; Sahin D; Telli TA; Salva H; Tuylu TB; Babacan NA; Kaya S; Dane F; Ones T; Alkis H; Adli M; Yumuk F
Clin Transl Oncol; 2019 Apr; 21(4):499-504. PubMed ID: 30229391
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma.
Cacicedo J; Fernandez I; Del Hoyo O; Navarro A; Gomez-Iturriaga A; Pijoan JI; Martinez-Indart L; Escudero J; Gomez-Suarez J; de Zarate RO; Perez JF; Bilbao P; Rades D
Clin Transl Oncol; 2017 Nov; 19(11):1337-1349. PubMed ID: 28540535
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Significance of Standardized Uptake Value of Lymph Nodes on Survival for Stage III Non-small Cell Lung Cancer Treated With Definitive Concurrent Chemoradiotherapy.
Lee VH; Chan WW; Lee EY; Choy TS; Ho PP; Leung DK; Lam KO; Kwong DL; Leung TW; Khong PL
Am J Clin Oncol; 2016 Aug; 39(4):355-62. PubMed ID: 24710123
[TBL] [Abstract][Full Text] [Related]
6. How much primary tumor metabolic volume reduction is required to improve outcome in stage III NSCLC after chemoradiotherapy? A single-centre experience.
Roengvoraphoj O; Eze C; Wijaya C; Dantes M; Taugner J; Tufman A; Huber RM; Bartenstein P; Belka C; Manapov F
Eur J Nucl Med Mol Imaging; 2018 Nov; 45(12):2103-2109. PubMed ID: 29876620
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of FDG uptake in primary inoperable non-small cell lung cancer.
Tong AN; Han SR; Yan P; Gong H; Zhao H; Yao H; Wang YM
Med Oncol; 2014 Jan; 31(1):780. PubMed ID: 24326983
[TBL] [Abstract][Full Text] [Related]
8. Areas of high 18F-FDG uptake on preradiotherapy PET/CT identify preferential sites of local relapse after chemoradiotherapy for non-small cell lung cancer.
Calais J; Thureau S; Dubray B; Modzelewski R; Thiberville L; Gardin I; Vera P
J Nucl Med; 2015 Feb; 56(2):196-203. PubMed ID: 25572091
[TBL] [Abstract][Full Text] [Related]
9. Preoperative Standardized Uptake Value of Metastatic Lymph Nodes Measured by 18F-FDG PET/CT Improves the Prediction of Prognosis in Gastric Cancer.
Song BI; Kim HW; Won KS; Ryu SW; Sohn SS; Kang YN
Medicine (Baltimore); 2015 Jul; 94(26):e1037. PubMed ID: 26131811
[TBL] [Abstract][Full Text] [Related]
10. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
11. To evaluate the treatment response of locally advanced esophageal cancer after preoperative chemoradiotherapy by FDG-PET/CT scan.
Huang JW; Yeh HL; Hsu CP; Lu YY; Chuang CY; Lin JC; Lin JF; Chang CF
J Chin Med Assoc; 2015 Apr; 78(4):229-34. PubMed ID: 25557468
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of nodal maximum standardized uptake value of pretreatment [18F]fluorodeoxyglucose positron emission tomography imaging in patients with esophageal cancer.
Yap WK; Chang YC; Tseng CK; Hsieh CH; Chao YK; Su PJ; Hou MM; Yang CK; Pai PC; Lin CR; Hsieh CE; Wu YY; Hung TM
Dis Esophagus; 2017 Aug; 30(8):1-10. PubMed ID: 28575243
[TBL] [Abstract][Full Text] [Related]
13. Volume-Based Assessment With 18F-FDG PET/CT Improves Outcome Prediction for Patients With Stage IIIA-N2 Non-Small Cell Lung Cancer.
Hyun SH; Ahn HK; Ahn MJ; Ahn YC; Kim J; Shim YM; Choi JY
AJR Am J Roentgenol; 2015 Sep; 205(3):623-8. PubMed ID: 26295651
[TBL] [Abstract][Full Text] [Related]
14. Is post-treatment standardized uptake value a prognostic factor in unresectable non-small cell lung carcinoma?
Yılmaz U; Yasar Z; Korkmaz E; Yalcın B; Koparal H; Ozbilek E
Med Glas (Zenica); 2017 Aug; 14(2):204-210. PubMed ID: 28698535
[TBL] [Abstract][Full Text] [Related]
15. Ratio of Lymph Node to Primary Tumor SUV on PET/CT Accurately Predicts Nodal Malignancy in Non-Small-Cell Lung Cancer.
Mattes MD; Moshchinsky AB; Ahsanuddin S; Rizk NP; Foster A; Wu AJ; Ashamalla H; Weber WA; Rimner A
Clin Lung Cancer; 2015 Nov; 16(6):e253-8. PubMed ID: 26163919
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic Body Radiotherapy for Medically Inoperable Stage I-II Non-Small Cell Lung Cancer: The Mayo Clinic Experience.
Hobbs CJ; Ko SJ; Paryani NN; Accurso JM; Olivier KR; Garces YI; Park SS; Hallemeier CL; Schild SE; Vora SA; Ashman JB; Rule WG; Bowers JR; Heckman MG; Diehl NN; Miller RC
Mayo Clin Proc Innov Qual Outcomes; 2018 Mar; 2(1):40-48. PubMed ID: 30225431
[TBL] [Abstract][Full Text] [Related]
17. Prognostic importance of
Kanyilmaz G; Benli Yavuz B; Aktan M; Sahin O
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(1):20-26. PubMed ID: 31668790
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia with 18F-fluoroerythronitroimidazole integrated positron emission tomography and computed tomography (18F-FETNIM PET/CT) in locoregionally advanced head and neck cancer: Hypoxia changes during chemoradiotherapy and impact on clinical outcome.
Hu M; Xie P; Lee NY; Li M; Ho F; Lian M; Zhao S; Yang G; Fu Z; Zheng J; Ma L; Yu J
Medicine (Baltimore); 2019 Oct; 98(40):e17067. PubMed ID: 31577699
[TBL] [Abstract][Full Text] [Related]
19. Intratumoral Metabolic Heterogeneity for Prediction of Disease Progression After Concurrent Chemoradiotherapy in Patients with Inoperable Stage III Non-Small-Cell Lung Cancer.
Kang SR; Song HC; Byun BH; Oh JR; Kim HS; Hong SP; Kwon SY; Chong A; Kim J; Cho SG; Park HJ; Kim YC; Ahn SJ; Min JJ; Bom HS
Nucl Med Mol Imaging; 2014 Mar; 48(1):16-25. PubMed ID: 24900134
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of maximum standardized uptake value on
Qiu X; Liang H; Zhong W; Zhao J; Chen M; Zhu Z; Xu Y; Wang M
Thorac Cancer; 2021 Mar; 12(6):845-853. PubMed ID: 33512768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
